157 related articles for article (PubMed ID: 3019133)
1. Processing of types I and III procollagen in Ehlers-Danlos syndrome type VII.
Halila R; Steinmann B; Peltonen L
Am J Hum Genet; 1986 Aug; 39(2):222-31. PubMed ID: 3019133
[TBL] [Abstract][Full Text] [Related]
2. Human dermatosparaxis: a form of Ehlers-Danlos syndrome that results from failure to remove the amino-terminal propeptide of type I procollagen.
Smith LT; Wertelecki W; Milstone LM; Petty EM; Seashore MR; Braverman IM; Jenkins TG; Byers PH
Am J Hum Genet; 1992 Aug; 51(2):235-44. PubMed ID: 1642226
[TBL] [Abstract][Full Text] [Related]
3. A base substitution at the splice acceptor site of intron 5 of the COL1A2 gene activates a cryptic splice site within exon 6 and generates abnormal type I procollagen in a patient with Ehlers-Danlos syndrome type VII.
Chiodo AA; Hockey A; Cole WG
J Biol Chem; 1992 Mar; 267(9):6361-9. PubMed ID: 1556139
[TBL] [Abstract][Full Text] [Related]
4. In vivo and in vitro noncovalent association of excised alpha 1 (I) amino-terminal propeptides with mutant pN alpha 2(I) collagen chains in native mutant collagen in a case of Ehlers-Danlos syndrome, type VII.
Wirtz MK; Keene DR; Hori H; Glanville RW; Steinmann B; Rao VH; Hollister DW
J Biol Chem; 1990 Apr; 265(11):6312-7. PubMed ID: 2318855
[TBL] [Abstract][Full Text] [Related]
5. Low production of procollagen III by skin fibroblasts from patients with Ehlers-Danlos syndrome type IV is not caused by decreased levels of procollagen III mRNA.
Aumailley M; Pöschl E; Martin GR; Yamada Y; Müller PK
Eur J Clin Invest; 1988 Apr; 18(2):207-12. PubMed ID: 3133227
[TBL] [Abstract][Full Text] [Related]
6. Ehlers-Danlos syndrome IV due to a novel defect in type III procollagen.
Pyeritz RE; Stolle CA; Parfrey NA; Myers JC
Am J Med Genet; 1984 Nov; 19(3):607-22. PubMed ID: 6507506
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of an altered type III procollagen in a patient with type IV Ehlers-Danlos syndrome. A structural change in the alpha 1(III) chain which makes the protein more susceptible to proteinases.
Stolle CA; Pyeritz RE; Myers JC; Prockop DJ
J Biol Chem; 1985 Feb; 260(3):1937-44. PubMed ID: 2981879
[TBL] [Abstract][Full Text] [Related]
8. Ehlers Danlos syndrome type VIIB. Incomplete cleavage of abnormal type I procollagen by N-proteinase in vitro results in the formation of copolymers of collagen and partially cleaved pNcollagen that are near circular in cross-section.
Watson RB; Wallis GA; Holmes DF; Viljoen D; Byers PH; Kadler KE
J Biol Chem; 1992 May; 267(13):9093-100. PubMed ID: 1577745
[TBL] [Abstract][Full Text] [Related]
9. Further evidence that the failure to cleave the aminopropeptide of type I procollagen is the cause of Ehlers-Danlos syndrome type VII.
Ho KK; Kong RY; Kuffner T; Hsu LH; Ma L; Cheah KS
Hum Mutat; 1994; 3(4):358-64. PubMed ID: 8081389
[TBL] [Abstract][Full Text] [Related]
10. A base substitution at a splice site in the COL3A1 gene causes exon skipping and generates abnormal type III procollagen in a patient with Ehlers-Danlos syndrome type IV.
Cole WG; Chiodo AA; Lamande SR; Janeczko R; Ramirez F; Dahl HH; Chan D; Bateman JF
J Biol Chem; 1990 Oct; 265(28):17070-7. PubMed ID: 2145268
[TBL] [Abstract][Full Text] [Related]
11. Haploinsufficiency for one COL3A1 allele of type III procollagen results in a phenotype similar to the vascular form of Ehlers-Danlos syndrome, Ehlers-Danlos syndrome type IV.
Schwarze U; Schievink WI; Petty E; Jaff MR; Babovic-Vuksanovic D; Cherry KJ; Pepin M; Byers PH
Am J Hum Genet; 2001 Nov; 69(5):989-1001. PubMed ID: 11577371
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a COL1A1 splicing defect in a case of Ehlers-Danlos syndrome type VII: further evidence of molecular homogeneity.
D'Alessio M; Ramirez F; Blumberg BD; Wirtz MK; Rao VH; Godfrey MD; Hollister DW
Am J Hum Genet; 1991 Aug; 49(2):400-6. PubMed ID: 1867198
[TBL] [Abstract][Full Text] [Related]
13. Aberrant splicing of the type III procollagen mRNA leads to intracellular degradation of the protein in a patient with Ehlers-Danlos type IV.
Thakker-Varia S; Anderson DW; Kuivaniemi H; Tromp G; Shin HG; van der Rest M; Glorieux FH; Ala-Kokko L; Stolle CA
Hum Mutat; 1995; 6(2):116-25. PubMed ID: 7581395
[TBL] [Abstract][Full Text] [Related]
14. The clinical features of Ehlers-Danlos syndrome type VII due to a deletion of 24 amino acids from the pro alpha 1(I) chain of type I procollagen.
Cole WG; Evans R; Sillence DO
J Med Genet; 1987 Nov; 24(11):698-701. PubMed ID: 3430546
[TBL] [Abstract][Full Text] [Related]
15. Human Ehlers-Danlos syndrome type VII C and bovine dermatosparaxis are caused by mutations in the procollagen I N-proteinase gene.
Colige A; Sieron AL; Li SW; Schwarze U; Petty E; Wertelecki W; Wilcox W; Krakow D; Cohn DH; Reardon W; Byers PH; Lapière CM; Prockop DJ; Nusgens BV
Am J Hum Genet; 1999 Aug; 65(2):308-17. PubMed ID: 10417273
[TBL] [Abstract][Full Text] [Related]
16. Another mechanism for the defect in type III collagen accumulation in Ehlers-Danlos syndrome type IV: increased intracellular degradation of the procollagen.
Utani A; Tanaka T; Nishigori C; Miyachi Y; Danno K; Imamura S; Hosokawa M; Takeda T; Hirayoshi K; Nagata K
Lab Invest; 1990 Aug; 63(2):181-8. PubMed ID: 2199725
[TBL] [Abstract][Full Text] [Related]
17. Regulation of procollagen amino-propeptide processing during mouse embryogenesis by specialization of homologous ADAMTS proteases: insights on collagen biosynthesis and dermatosparaxis.
Le Goff C; Somerville RP; Kesteloot F; Powell K; Birk DE; Colige AC; Apte SS
Development; 2006 Apr; 133(8):1587-96. PubMed ID: 16556917
[TBL] [Abstract][Full Text] [Related]
18. The mRNA and the activity of lysyl hydroxylase are up-regulated by the administration of ascorbate and hydralazine to human skin fibroblasts from a patient with Ehlers-Danlos syndrome type VI.
Yeowell HN; Walker LC; Marshall MK; Murad S; Pinnell SR
Arch Biochem Biophys; 1995 Aug; 321(2):510-6. PubMed ID: 7646078
[TBL] [Abstract][Full Text] [Related]
19. Evidence for a relationship between Ehlers-Danlos type VII C in humans and bovine dermatosparaxis.
Nusgens BV; Verellen-Dumoulin C; Hermanns-Lê T; De Paepe A; Nuytinck L; Piérard GE; Lapière CM
Nat Genet; 1992 Jun; 1(3):214-7. PubMed ID: 1303238
[TBL] [Abstract][Full Text] [Related]
20. Molecular defects of type III procollagen in Ehlers-Danlos syndrome type IV.
Superti-Furga A; Steinmann B; Ramirez F; Byers PH
Hum Genet; 1989 May; 82(2):104-8. PubMed ID: 2722184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
